Compare Lemonade Inc (LMND) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lemonade Inc vs Tempus AI — how do they compare? Lemonade Inc trades at $53.08 (market cap $4.08B), while Tempus AI trades at $55.61 (market cap $9.93B). The key difference: Tempus AI is far larger — about 2.4× Lemonade Inc's market cap, and Tempus AI is trading nearer its 52-week high, Lemonade Inc nearer its low. Which is the better fit depends on your goals.
| LMND | TEM | |
|---|---|---|
Market Cap | $4.08B | $9.93B |
Sector | Financials | Broad Market / Factor |
52-Week High | $96.57 | $103.25 |
52-Week Low | $47.38 | $41.55 |
Enterprise Value | $3.94B | $10.56B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Lemonade (LMND) trades at $52.94, up 2.08% today, with a bearish technical signal from moving averages despite recent earnings beats. Revenue growth is strong at 79% year-over-year in Q2 2026, but profitability remains elusive with a net income margin of -14.19% in 2025. The company targets positive adjusted EBITDA by Q4 2026, supported by expanding insurance offerings in states like Nebraska and Maine.
The outlook is mixed: accelerating premium growth and path to profitability offer upside, but high valuation (P/S of 4.11) and persistent losses pose risks. Analyst consensus is evenly split, with a $58 price target suggesting modest upside from current levels, though technical resistance near $54 may limit near-term gains.
Tempus AI (TEM) trades at $52.05, up 12.86% in 24 hours, reflecting strong momentum after Q2 2026 earnings beat revenue estimates and raised 2026 sales guidance. The stock is technically bullish with moving averages supporting upside, while fundamentals show revenue growth to $1.4 billion in 2026 but persistent net losses. Recent news highlights expansion through the Personalis acquisition and AI-driven precision medicine advancements.
Outlook: Growth prospects are robust with AI adoption in healthcare and strategic deals, but high valuation ratios and negative profitability pose risks. Analysts are bullish with a $61.57 consensus target, though cash burn and competitive pressures require monitoring for sustained investor confidence.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Lemonade Inc
Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes.
Read more on LMND →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
